Figures & data
Figure 2. Diagrammatic illustration of signaling pathways and molecular targets of 3-Acetyl-11-keto-β-boswellic acid (AKBA) in rheumatoid arthritis. Abbreviations: AKBA: 3-Acetyl-11-keto-β-boswellic Acid; NF-κB: nuclear factor kappa B; IL: Interleukin; TNF-α: tumor necrosis factor-alpha; CD4: clusters of differentiation 4; RF: rheumatoid factors; APC: antigen-presenting cells; RANKL: receptor activator of nuclear factor-kappa B ligand; PLA2: phospholipase A2; FLAP: 5-lipoxygenase activating protein; 5-LOX: 5-lipoxygenase; LT (A4, B4, C4, D4, E4): leukotriene (A4, B4, C4, D4, E4).
![Figure 2. Diagrammatic illustration of signaling pathways and molecular targets of 3-Acetyl-11-keto-β-boswellic acid (AKBA) in rheumatoid arthritis. Abbreviations: AKBA: 3-Acetyl-11-keto-β-boswellic Acid; NF-κB: nuclear factor kappa B; IL: Interleukin; TNF-α: tumor necrosis factor-alpha; CD4: clusters of differentiation 4; RF: rheumatoid factors; APC: antigen-presenting cells; RANKL: receptor activator of nuclear factor-kappa B ligand; PLA2: phospholipase A2; FLAP: 5-lipoxygenase activating protein; 5-LOX: 5-lipoxygenase; LT (A4, B4, C4, D4, E4): leukotriene (A4, B4, C4, D4, E4).](/cms/asset/a0a0b1f0-aee7-4819-846c-e9aed05852b6/ieid_a_2269838_f0002_oc.jpg)
Table 1. 3-Acetyl-11-keto-β-boswellic acid (AKBA) loaded nanocarrier system for exploring its anti-inflammatory and anti-arthritic potential.